167 related articles for article (PubMed ID: 32340037)
1. Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia.
Fink HA; Linskens EJ; MacDonald R; Silverman PC; McCarten JR; Talley KMC; Forte ML; Desai PJ; Nelson VA; Miller MA; Hemmy LS; Brasure M; Taylor BC; Ng W; Ouellette JM; Sheets KM; Wilt TJ; Butler M
Ann Intern Med; 2020 May; 172(10):656-668. PubMed ID: 32340037
[TBL] [Abstract][Full Text] [Related]
2. Brief Cognitive Tests for Distinguishing Clinical Alzheimer-Type Dementia From Mild Cognitive Impairment or Normal Cognition in Older Adults With Suspected Cognitive Impairment.
Hemmy LS; Linskens EJ; Silverman PC; Miller MA; Talley KMC; Taylor BC; Ouellette JM; Greer NL; Wilt TJ; Butler M; Fink HA
Ann Intern Med; 2020 May; 172(10):678-687. PubMed ID: 32340040
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review.
Fink HA; Jutkowitz E; McCarten JR; Hemmy LS; Butler M; Davila H; Ratner E; Calvert C; Barclay TR; Brasure M; Nelson VA; Kane RL
Ann Intern Med; 2018 Jan; 168(1):39-51. PubMed ID: 29255847
[TBL] [Abstract][Full Text] [Related]
4. Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review.
Butler M; Nelson VA; Davila H; Ratner E; Fink HA; Hemmy LS; McCarten JR; Barclay TR; Brasure M; Kane RL
Ann Intern Med; 2018 Jan; 168(1):52-62. PubMed ID: 29255909
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of Biomarker Testing for Neuropathologically Defined Alzheimer Disease in Older Adults With Dementia.
Fink HA; Linskens EJ; Silverman PC; McCarten JR; Hemmy LS; Ouellette JM; Greer NL; Wilt TJ; Butler M
Ann Intern Med; 2020 May; 172(10):669-677. PubMed ID: 32340038
[TBL] [Abstract][Full Text] [Related]
6. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P
Drugs Aging; 2019 May; 36(5):435-452. PubMed ID: 30937879
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of pharmacotherapy for Alzheimer's disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials.
Seibert M; Mühlbauer V; Holbrook J; Voigt-Radloff S; Brefka S; Dallmeier D; Denkinger M; Schönfeldt-Lecuona C; Klöppel S; von Arnim CAF
Alzheimers Res Ther; 2021 Jul; 13(1):131. PubMed ID: 34271969
[TBL] [Abstract][Full Text] [Related]
8. Rivastigmine for Alzheimer's disease.
Birks JS; Grimley Evans J
Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
[TBL] [Abstract][Full Text] [Related]
9. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
[TBL] [Abstract][Full Text] [Related]
10. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.
Raina P; Santaguida P; Ismaila A; Patterson C; Cowan D; Levine M; Booker L; Oremus M
Ann Intern Med; 2008 Mar; 148(5):379-97. PubMed ID: 18316756
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
Kavirajan H; Schneider LS
Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
[TBL] [Abstract][Full Text] [Related]
13. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
Malouf R; Grimley Evans J
Cochrane Database Syst Rev; 2008 Oct; (4):CD004514. PubMed ID: 18843658
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
Qizilbash N; Whitehead A; Higgins J; Wilcock G; Schneider L; Farlow M
JAMA; 1998 Nov; 280(20):1777-82. PubMed ID: 9842955
[TBL] [Abstract][Full Text] [Related]
15. Selegiline for Alzheimer's disease.
Birks J; Flicker L
Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin for osteoarthritis.
Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
[TBL] [Abstract][Full Text] [Related]
17. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
